Home  »  Ipo Review  »  Sahajanand Medical Technologies Ipo

Let’s have a detailed review of the company and analytics of the Sahajanand Medical Technologies IPO release date, SMT IPO offer price, subscription, Sahajanand Medical Technologies Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.

Face Value Rs 1
Price Band Rs [●]
Listing At BSE, NSE
Min. Order Quantity NA
Listing Date NA
Offer for Sale Rs 10,896.70 Million
Fresh Issue Rs 4,103.30 Million
IPO Size Rs 15,000 Million
Tick Size 1

Sahajanand Medical Technologies IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.

Sahajanand Medical Technologies IPO – Summary

Sahajanand Medical Technologies IPOThey are a leading medical devices company that researches, designs, develops, manufactures, and markets vascular devices globally. They differentiate their product offering in these categories by providing their customers with high-quality products at market appropriate prices supported by strong clinical data.

This combination has led them to a leading market share in the drug-eluting stent (“DES”) market in India, with a market share of 21%, 25%, and 31% in Fiscals 2019, 2020, and 2021, respectively, of the total DES sales volume in India. They are among the top five companies in terms of market share (by sales volume of DES) in each of Germany, Netherlands, Italy, and Poland, as of March 31, 2021 (Frost & Sullivan).


Sahajanand Medical Technologies IPO Date

The opening and the closing date of Sahajanand Medical Technologies IPO are not available yet.

Check out Related IPO Links:

Sahajanand Medical Technologies IPO GMP
Allotment – Sahajanand Medical Technologies IPO

Sahajanand Medical Technologies IPO Subscription

Day / Date QIB NII RII Total Subscription
1st Day – 
2nd Day –  
3rd Day – 
Shares Offered or Net Issue

The shares subscribed by the public will be updated here.

Check Sahajanand Medical Technologies IPO LIVE Subscription

  • Sahajanand Medical Technologies IPO LIVE Bid details on BSE
  • Sahajanand Medical Technologies IPO LIVE Bid details on NSE

For the Latest Bid details click on the above links.

Sahajanand Medical Technologies IPO Allotment Status

Here, you can find the Allotment Status of this IPO.

Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.

SMT Limited IPO Listing Date

Find the dates below on basis of allotment, refund, listing, and more:

Basis of Allotment Finalization
Refunds Initiation
Credit of Shares to Demat Account
Share Listing Date

Sahajanand Medical Technologies IPO Price Band 

The face value of each share is Rs.1, but the price band of the IPO is Rs.[●] 

Sahajanand Medical Technologies IPO Size

This Initial Public Issue of X Equity Shares of Rs.1 each for cash at a price of Rs.[●]  per equity share aggregating to Rs.15,000 Million.

Sahajanand Medical Technologies IPO Share Offering

Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of [●] Equity Shares of Rs.1/ each.

Issue Size: X Equity Shares of Rs.1 each, aggregating to Rs.15,000 Million

Open Free Demat Account Now!

    Fill Your Details Here
    1. Open Demat AccountInvest in IPO

    Sahajanand Medical Technologies IPO – Live Performance

    The listing date of this IPO is [●]. You can check the live performance of the IPO here, only after it is listed on exchanges.

    Live IPO Performance – Sahajanand Medical Technologies Share Price

    SMT IPO Grey Market Premium

    The Sahajanand Medical Technologies Limited IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is X. 

    Sahajanand Medical Technologies IPO – Company Overview

    Their Company was founded by Mr. Dhirajlal Kotadia who grew up as a young boy through the plight of poverty. As an adult, Mr. Kotadia was moved after witnessing a poor man struggling to pay for his dying wife’s medicines. This event inspired Mr. Kotadia to create a company that would focus on making critical life-saving products accessible to the masses that ultimately led to him establishing their Company in 2001.

    Their Company has been driven by their “Pledge to Save Millions” – millions of lives, and millions of Rupees for millions of families around the world. Under Mr. Kotadia’s leadership, their Company became the first company in the world to receive CE certification for a DES with a biodegradable polymer and they also launched one of the lowest strut thickness stents with a 60-micron thickness.

    They believe that their ongoing research and development (“R&D”) efforts enable them to continue to develop innovative and technologically advanced products while their operational scale helps them produce products that are affordable for the masses.

    They constantly seek to enhance their existing products and portfolio while optimizing their manufacturing processes for greater efficiencies. Also, they operate three research and development facilities, located in Surat, India, Galway, Ireland, and Nonthaburi, Thailand. Their R&D efforts have led to the development of several key technologies in the vascular devices industry, including their biodegradable polymer in 2005.

    Sahajanand Medical Technologies IPO – Financial Statements

    A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:

    Financial Summary:

    Amount (in INR & Million)
    31-Mar-21 31-Mar-20 Mar-19
    Total Assets 8,619.55 6,317.84 5,203.67
    *Total Revenue 5,919.59 4,903.06 3,359.45
    Total Expense 5,965.10 4,524.53 2,907.42
    Profit After Tax (723.38) 254.35 334.30

    Earnings per Equity Share (in Million)

    31-Mar-21 31-Mar-20 Mar-19
    Basic  (8.13) 2.76 4.00
    Diluted (8.13) 2.69 3.67


    Further, their PAT for the period ended on March 31, 2021, March 31, 2020, and March 31, 2019, were Rs. (723.38) Million, Rs. 254.35 Million and Rs. 334.30 Million respectively.

    Sahajanand Medical Technologies IPO – Promoters

    The Promoter of this company is:


    List of Related Parties (Key Managerial Personnel)

    • Dhirajlal Vallabhbhai Kotadia, Chairman
    • Bhargav Dhirajlal Kotadia, Managing Director
    • Abhishek Rajendrakumar Kabra, Non-Executive Investor Director
    • Jose Calle Gordo Non-Executive Director
    • Lalit Chandra Reddy, Independent Director
    • Ranjal Laxmana Shenoy, Independent Director

    Sahajanand Medical IPO – Promoters Holding

    • Pre Issue Share Holding – %
    • Pos Issue Share Holding – %

    SMT IPO Offer Details or Issue Details

     Particulars  No. Of Equity Shares
     Equity Shares Offered  Up to X Equity Shares aggregating up to Rs.15,000 Million
    of which:
    Issue Reserved for the Market Makers Up to [●] Equity Shares aggregating up to Rs.[●]
    Net Issue to the Public Up to [●] Equity Shares aggregating up to Rs.[●]
    Of which:
    Retail Investors Portion Not less than [●] Equity Shares
    Other than Retail Individual Investors Not more than [●] Equity Shares
     Equity Shares outstanding prior to the Issue 8,89,04,343 Equity Shares
     Equity Shares outstanding after the Issue X Equity Shares

    Sahajanand Medical Technologies IPO Issue Object

    Their Company proposes to utilize the Net Proceeds towards funding the following objects:

    1. Repayment/ prepayment of certain indebtedness availed by their Company and their Subsidiaries;
    2. Funding the working capital requirements of their indirect foreign subsidiary, Vascular Innovations Co. Ltd. (“Vascular Innovations”); and
    3. General corporate purposes.

    Sahajanand Medical – Business Strategy

    • Leverage existing relationships by capturing cross-selling synergy in high growth vascular products and continue market leadership in India.
    • They continue to expand their international business
    • Continue to develop and optimize niche and high-value products
    • Continue to explore strategic partnerships and acquisition opportunities to fast track their growth and become a global vascular device player
    • Improve margins through captive consumption, efficiency in sales and marketing, and improvements in working capital

    Sahajanand Medical IPO – Basis of Offer Price

    The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.

    Qualitative factors are:

    • Technologically advanced products in an industry with high barriers to entry;
    • Market-leading position in interventional cardiology in India, leveraging on industry growth drivers;
    • Fast growth in international markets;
    • Robust and efficient manufacturing capabilities generating healthy margins;
    • Proven R&D capabilities; and
    • Experienced and stable leadership team supported by a highly-skilled employee base

    The relevant quantitative factors are:

    Basic EPS Diluted EPS RONW (%) NAV (Rs.)
    31-Mar-21 (8.13) (8.13) (21.06) 38.62
    31-Mar-20 2.76 2.69 5.92
    Mar-19 4.00 3.67 8.57

    Sahajanand Medical Technologies IPO: Competitive Peers

    Face Value (Rs.) P/E EPS  (Rs.) Return on Net Worth (%) Total Income (Rs. in Millions)
    Sahajanand Medical Technologies Limited 1 [●] (8.13) (21.06) 5,919.59
    Listed Peers

    Sahajanand Medical Technologies IPO Lead Managers

    Lead Managers




    Sahajanand Medical Technologies IPO Registrar to offer

    Registrar to the Offer
    C 101, 247 Park, L. B. S. Marg
    Vikhroli (West)
    Mumbai 400 083
    Tel: +91 22 4918 6200
    E-mail: smt.ipo@linkintime.co.in
    Investor grievance e-mail:
    Website: www.linkintime.co.in
    Contact person: Shanti Gopalkrishnan
    SEBI Registration Number:

    Sahajanand Medical IPO – Other Details

    • Statutory Auditor – Deloitte Haskins & Sells LLP Chartered Accountants
    • Legal Counsel to the Company – IndusLaw
    • Bankers to the Company –  Standard Chartered Bank and HDFC Bank Limited

    Sahajanand Medical IPO Review by Stock Brokers

    Top Stock Brokers Review Company Reputation Competitive Edge Financial Statement Popularity Index Promoters Reputation
    Angel Broking 7.5/10 7.4/10 8.5/10 8.1/10 7.1/10
    Sharekhan 7.2/10 7.1/10 8.6/10 8.1/10 7.2/10
    Kotak Securities 7.3/10 7.5/10 8.4/10 8.1/10 7.3/10
    ICICI Direct 7.3/10 7.3/10 8.7/10 8.1/10 7.1/10
    IIFL 7.5/10 7.2/10 8.8/10 8.0/10 7.1/10
    Edelweiss 7.5/10 7.4/10 8.4/10 8.3/10 7.2/10
    Zerodha 7.4/10 7.1/10 8.5/10 8.1/10 7.0/10
    5Paisa 7.1/10 7.1/10 8.4/10 8.1/10 7.1/10
    Karvy 7.4/10 7.3/10 8.2/10 8.1/10 7.1/10
    Motilal Oswal 7.1/10 7.1/10 8.6/10 8.3/10 7.2/10


    Subscribe to Sahajanand Medical Technologies IPO

      Fill Your Details Here
      1. Open Demat AccountInvest in IPO

      Sahajanand Medical Technologies Limited IPO News

      News 1 – IPO DRHP Download

      News 2 – IPO RHP Prospectus Download

      Sahajanand Medical Technologies IPO Review FAQs

      Ques – What is the Issue Size of Sahajanand Medical IPO?

      Answer – The Company is making an initial public offer of NA equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.

      Ques – What is the Price band of Sahajanand Medical Technologies IPO?

      Answer – The price band for this particular IPO ranges between NA. As far as the face value of the share is of concern, it is Rs.1 per share.

      Ques – What is the Sahajanand Medical Technologies IPO Open Date?

      Answer – The opening and closing dates for this IPO have been updated. The IPO is set to open on NA, while the closing date is set at NA.

      Ques – What is the Sahajanand Medical IPO Allotment Date?

      Answer – They also have the news regarding the respective allotment dates of this IPO. Basis of Allotment finalization is on NA, refund initiation is on NA, credit of shares is on NA, and share listing date is on NA.

      Ques – What is the Sahajanand Medical IPO Listing Date?

      Answer – Shares of this company shall be listed in the exchanges NA. The date, when the listing would be done, is stagnant on NA.

      Ques – Who is the Registrar of Sahajanand Medical IPO?

      Answer – One of the reputed registrars is managing the issue of this IPO, i.e. LINK INTIME INDIA PRIVATE LIMITED. Their website will help you regarding the further information you are on the lookout for.

      Ques – Who is the Promoter of Sahajanand Medical Technologies IPO?

      Answer – Here are the promoters of this IPO – BHARGAV DHIRAJLAL KOTADIA AND SHREE HARI TRUST. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.

      Ques – What is the GMP of Sahajanand Medical IPO?

      Answer – They have obtained the GMP of this IPO and it is NA. Further insights of Kostak rate and subject to sauda or SS are as well included in this report.

      Ques – Is Sahajanand Medical IPO good for Investment?

      Answer – They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.

      Ques – What is the PAT of Sahajanand Medicals?

      Answer – They have the information of company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2021 in Million is (723.38), 2020 is 254.35, 2019 is 334.30.

      Calculate your return on investment!

      Asset Class ROI (Rs.) Profit (Rs.) Profit (%)
      Real Estate
      Fixed Deposit
      Mutual Fund

      Featured Topics


      Get 100% IPO Allotment Guarantee! Subscribe to IPO